Home Cart 0 Sign in  
X

[ CAS No. 75893-75-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 75893-75-3
Chemical Structure| 75893-75-3
Chemical Structure| 75893-75-3
Structure of 75893-75-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 75893-75-3 ]

Related Doc. of [ 75893-75-3 ]

Alternatived Products of [ 75893-75-3 ]
Product Citations

Product Details of [ 75893-75-3 ]

CAS No. :75893-75-3 MDL No. :MFCD18255573
Formula : C9H9NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :AZQLYGCISPLJER-UHFFFAOYSA-N
M.W : 163.17 Pubchem ID :12440058
Synonyms :

Calculated chemistry of [ 75893-75-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.66
TPSA : 50.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.62 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.44
Log Po/w (XLOGP3) : 0.95
Log Po/w (WLOGP) : 1.59
Log Po/w (MLOGP) : -0.13
Log Po/w (SILICOS-IT) : 1.75
Consensus Log Po/w : 1.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.69
Solubility : 3.35 mg/ml ; 0.0205 mol/l
Class : Very soluble
Log S (Ali) : -1.59
Solubility : 4.18 mg/ml ; 0.0256 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.99
Solubility : 1.68 mg/ml ; 0.0103 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.55

Safety of [ 75893-75-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 75893-75-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 75893-75-3 ]

[ 75893-75-3 ] Synthesis Path-Downstream   1~7

  • 1
  • 4-phenyldecahydroquinolin-4-ol [ No CAS ]
  • [ 75893-75-3 ]
  • C24H28N2O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With water; sodium hydroxide; In ethanol; for 20.0h;Reflux; General procedure: Intermediate 6A: 5-Iso ropyl-3-methyI-lH-pyrazole-4-carboxylic acidEthyl 5-isopropyl-3-methyl-lH-pyrazole-4-carboxylate (WO2009/013211) (2.1 g, 10.7 mmol) was dissolved in ethanohwater (2:1, 10 mL), to it was added sodium hydroxide (857 mg, 21.4 mmol) and refluxed for 20 h. Volatiles were evaporated under reduced pressure. Aqueous layer was diluted with water (20 mL) and extracted with ethyl acetate (2 X 20 mL). Combined organic layer was washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated to give 750 mg (73%) of 5 -isopropyl-3 -methyl- 1H- pyrazole-4-carboxylic acid.? NMR (400 MHz, CDCI3): delta 1.17 (d, J = 6.9 Hz, 6H), 2.32 (s, 3H), 3.45-3.54 (m, 1H), 12.23 (brs, 2H). MS (ES) m/z 169.1 (M+l).
With sodium hydroxide; In ethanol; water; for 20.0h;Reflux; General procedure: Intermediate 6A: 5-Isopropyl-3-methyl-1H-pyrazole-4-carboxylic acid Ethyl 5-isopropyl-3-methyl-1H-pyrazole-4-carboxylate (WO2009/013211) (2.1 g, 10.7 mmol) was dissolved in ethanol:water (2:1, 10 mL), to it was added sodium hydroxide (857 mg, 21.4 mmol) and refluxed for 20 h. Volatiles were evaporated under reduced pressure. Aqueous layer was diluted with water (20 mL) and extracted with ethyl acetate (2*20 mL). Combined organic layer was washed with brine (25 mL), dried over anhydrous sodium sulfate, filtered and concentrated to give 750 mg (73%) of 5-isopropyl-3-methyl-1H-pyrazole-4-carboxylic acid. 1H NMR (400 MHz, CDCl3): delta 1.17 (d, J=6.9 Hz, 6H), 2.32 (s, 3H), 3.45-3.54 (m, 1H), 12.23 (brs, 2H). MS (ES) m/z 169.1 (M+1).
  • 3
  • [ 1147531-04-1 ]
  • [ 75893-75-3 ]
  • N-[2-[[tert-butyl(dimethyl)silyl]oxymethyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-6-cyclopropyl-pyridine-3-carboxamide [ No CAS ]
  • 4
  • [ 1147531-04-1 ]
  • [ 75893-75-3 ]
  • N-[3-bromo-2-[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]-6-cyclopropylpyridine-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
35% With 4-methyl-morpholine; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; at 20.0℃; for 16.0h; Step-6: Synthesis of N-[3-bromo-2-[[tert-butyI(dimethyl)siIyl]oxymethyl]phenyl]-6- cyclopropyl-pyridine-3-carboxamide: To a solution of <strong>[75893-75-3]6-cyclopropylpyridine-3-carboxylic acid</strong> (0.5 g, 3.06 mmol), 3-bromo-2-[[tert- butyl(dimethyl)silyl]oxymethyl]aniline (1.16 g, 3.67 mmol) and HOBt (0.495 g, 3.67 mmol) in DCM (15 mL) was added NMM (0.5 mL, 4-59 mmol) and EDCI.HCl (0.876 g, 4.59 mmol). The reaction mixture was stirred at room temperature for 16 h. After completion of the reaction (as indicated by TLC), water (10 mL) was added to it and extraction was carried out using DCM (50 mL x 2). The combined organic layers were washed with brine (50 mL), dried over anhydrous Na2S04, filtered and concentrated under reduced pressure. The residue was purified using column chromatography (Si02, 10% ethyl acetate in hexanes) to afford title compound (0.5 g, 35%). LCMS: m/z 461.2 (M + 1)+. NMR (400 MHz, CDC13) delta 0.15 (s, 6H), 0.87 (s, 9H), 1.05-1.10 (m, 2H), 1.1 1-1.51 (m, 2H), 2.06-2.16 (m, 1H), 5.1 1 (s, 2H), 7.19-7.23 (aromatics, 2H), 7.33 (d, J = 8.0 Hz, 1H), 8.03 (dd, J = 8.0, 2.0 Hz, 1H), 8.33 (d, J = 8.0 Hz, 1H), 8.99 (d, J = 2.0 Hz, lH), 9.99 (s, lH).
  • 5
  • [ 75893-75-3 ]
  • 2-fluoro-4-[2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]benzylamine [ No CAS ]
  • 6-cyclopropyl-N-([2-fluoro-4-[2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl)pyridine-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
13% With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; In N,N-dimethyl-formamide; at 20.0℃; for 16.0h;Inert atmosphere; Example 56 6-Cyclopropyl-N-([2-fluoro-4-[2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl)pyridine-3-carboxamide (56) In a 10-mL round bottom flask purged and maintained with an inert atmosphere of nitrogen, [2-fluoro-4-[2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methanamine (100 mg, 0.31 mmol, 1.00 equiv) and <strong>[75893-75-3]6-cyclopropylpyridine-3-carboxylic acid</strong> (60.7 mg, 0.37 mmol, 1.20 equiv) were dissolved in N,N-dimethylformamide (2 mL), to which were added HATU (176.9 mg, 0.47 mmol, 1.50 equiv) and DIEA (120.3 mg, 0.93 mmol, 3.00 equiv) in sequence at room temperature. The resulting solution was stirred for 16 h at room temperature. When the reaction was done, it was quenched by the addition of 5 mL water and the mixture was extracted with dichloromethane (3*10 mL). The organic layers were combined, dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by prep-HPLC using the following conditions: column, X Bridge C18, 19*150 mm, 5 um; mobile phase, acetonitrile in water (with 0.05% TFA), 30% to 70% gradient in 10 min; detector, UV, 254 nm. 6-cyclopropyl-N-([2-fluoro-4-[2-(1-methyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl)pyridine-3-carboxamide (20 mg, 13%) was obtained as white solid. HPLC: 97.7% purity. MS: m/z=468.1 [M+H]+. 1H NMR (400 MHz, DMSO-d6): 6 13.39 (br s, 1H), 9.20-9.17 (m, 1H), 8.91 (d, J=2.0 Hz, 1H), 8.44 (s, 1H), 8.29-8.20 (m, 2H), 8.14-8.11 (m, 3H), 7.56-7.52 (m, 2H), 7.42 (d, J=8.0 Hz, 1H), 4.60 (s, 2H), 3.94 (s, 3H), 2.33-2.15 (m, 1H), 1.05-1.01 (m, 4H).
  • 6
  • [ 75893-75-3 ]
  • 5-[(2R,3R)-3-amino-2-methylpiperidin-1-yl]-3-[4-(oxan-4-yloxy)phenyl]amino}pyrazine-2-carbonitrile [ No CAS ]
  • N-[(2R,3R)-1-(5-cyano-6-[4-(oxan-4-yloxy)phenyl]amino}pyrazin-2-yl)-2-methylpiperidin-3-yl]-6-cyclopropylpyridine-3-carboxamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
87% With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; N-ethyl-N,N-diisopropylamine; In N,N-dimethyl-formamide; at 20.0℃; for 1.0h; 5-[(2R,3R)-3-amino-2-methylpiperidin-1-yl]-3-[4-(oxan-4-yloxy)phenyl]amino}pyrazine-2- carbonitrile (102.8 mg, 0.25 mmol) was dissolved in DMF (4 mL), <strong>[75893-75-3]6-cyclopropylnicotinic acid</strong> (62 mg, 0.38 mmol), DIPEA (0.2 mL, 1.26 mmol) and PyBOP (196 mg, 0.38 mmol) were added. The mixture was stirred at room temperature 1 h. Water and DCM were added and the mixture was extracted with DCM. The organic phase was dried over Na2SO4, filtered and evaporated to give a crude which was purified by silica flash chromatography with 50% to 100% ethyl acetate in cyclohexane to afford N-[(2R,3R)-1-(5-cyano-6-[4-(oxan-4-yloxy)phenyl]amino}pyrazin-2- yl)-2-methylpiperidin-3-yl]-6-cyclopropylpyridine-3-carboxamide (120.7 mg, 87% yield) as a yellow solid. MS found for C31H35N7O3 as (M+H)+ 554.0.
  • 7
  • [ 75893-75-3 ]
  • 5-[(2R,3R)-3-amino-2-methylpiperidin-1-yl]-3-[4-(oxan-4-yloxy)phenyl]amino}pyrazine-2-carbonitrile [ No CAS ]
  • 5-[(2R,3R)-3-(6-cyclopropylpyridine-3-amido)-2-methylpiperidin-1-yl]-3-[4-(oxan-4-yloxy)phenyl]amino}pyrazine-2-carboxamide [ No CAS ]
Recommend Products
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 75893-75-3 ]

Carboxylic Acids

Chemical Structure| 1970-80-5

[ 1970-80-5 ]

(2,2-Bipyridine)-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 3222-47-7

[ 3222-47-7 ]

6-Methylnicotinic acid

Similarity: 0.86

Chemical Structure| 29051-44-3

[ 29051-44-3 ]

6-Phenylnicotinic acid

Similarity: 0.85

Chemical Structure| 1970-81-6

[ 1970-81-6 ]

[3,3'-Bipyridine]-5-carboxylic acid

Similarity: 0.83

Chemical Structure| 22047-86-5

[ 22047-86-5 ]

4,6-Dimethylnicotinic acid

Similarity: 0.81

Related Parent Nucleus of
[ 75893-75-3 ]

Pyridines

Chemical Structure| 1970-80-5

[ 1970-80-5 ]

(2,2-Bipyridine)-5-carboxylic acid

Similarity: 0.90

Chemical Structure| 3222-47-7

[ 3222-47-7 ]

6-Methylnicotinic acid

Similarity: 0.86

Chemical Structure| 29051-44-3

[ 29051-44-3 ]

6-Phenylnicotinic acid

Similarity: 0.85

Chemical Structure| 1970-81-6

[ 1970-81-6 ]

[3,3'-Bipyridine]-5-carboxylic acid

Similarity: 0.83

Chemical Structure| 5470-70-2

[ 5470-70-2 ]

Methyl 6-methylnicotinate

Similarity: 0.81